Anzeige
Mehr »
Login
Donnerstag, 28.11.2024 Börsentäglich über 12.000 News von 677 internationalen Medien
Die größte Bedrohung für Hightech - Milliarden-Chance für Anleger!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
533 Leser
Artikel bewerten:
(2)

InsightAce Analytic Pvt. Ltd.: Global Clinical Trials Software Market worth $ 4.13 billion by 2030 - Exclusive Report by InsightAce Analytic

Finanznachrichten News

JERSEY CITY, N.J., Jan. 25, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Clinical Trials Software Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030."

InsightAce_Analytic_Logo

Get the Sample Pages:https://www.insightaceanalytic.com/request-sample/1195

According to the latest research, the global clinical trials software market is valued at US$ 1.20 Billion in 2021, and it is expected to reach US$ 4.13 Billion by 2030, with a CAGR of 15.1% during the forecast period of 2022-2030. By region, North America dominated the global market with a share of 37% in 2021.

Clinical trials are an essential part of drug clinical research. Clinical trials are a major part of drug development processes and the discovery of new treatments and drugs for various diseases such as cancer and cardiovascular diseases. Advanced clinical trials software is widely used to improve data quality, management, and procedures of the research studies.

Increasing government funding for the development of clinical trial services, advancements in technologies, high demand for clinical trial management services is primarily driving the market growth. Rising R&D funding activities in clinical research, growing prevalence of chronic diseases, innovation of clinical trial planning & design services, developing healthcare infrastructure, and increasing use of cloud-based solutions by biopharma companies for clinical trial process automation are further likely to boost the market growth. There is a surge in clinical trial studies due to the rising prevalence of chronic diseases. Hence, biopharmaceutical companies adopt clinical trial management services to reduce process time and increase the efficiency and accuracy of clinical trials. Thus, it is expected to propel market growth opportunities in the next few years.

On the other side, the high cost of clinical trial software may hamper the market expansion over the forecast period.

Regionally, North America is expected to lead the global clinical trials software market during the forecast period (2022-2030), followed by Europe, owing to the increasing clinical R&D activities of pharma companies, fast adoption of cloud-based technologies, and rising prevalence of various diseases.

Request for ToC :https://www.insightaceanalytic.com/customisation/1195

Key market players operating in the clinical trials software market include Advarra, Antidote Technologies, Inc., ArisGlobal , AssistRx, athenahealth, Inc., Axiom Real-Time Metrics, BioClinica Inc. , BSI Business Systems Integration AG, Calyx , Castor EDC, Chronicles, Clario, Clarivate, ClinCapture, Clincase, Clinical Research, CLIRINX, Cloudbyz, Dacima Software Inc., Datatrak Int. , Florence HC , IBM , Instem , IQVIA , MasterControl Inc., Medidata Solutions Inc, MedNet Solutions Inc., Novatek International, Octalsoft , Openclinica, Oracle Corporation, Parexel International Corp., RealTime Software Solutions LLC, Reify Health, Inc., Signant Health, Statsols, TrialKit , Veeva Systems Inc., WIRB-Copernicus Group, and Other prominent players.

Key recent developments in the market:

  • In December 2021, Advarra (US), the market leader in clinical site technologies and research quality and compliance consulting services, launched Advarra Cloud. The next-generation platform broadens cloud deployment options for Advarra customers and delivers applications in an easy-to-use, fully managed environment.
  • In April 2021, Bioclinica (US) introduced the new source document management solution that combines advanced software with redaction and translation services to offer support to global research sites and trial management teams.
  • In April 2021, Calyx, the eClinical and regulatory solutions & services provider, released Calyx CTMS v15.0, an advanced clinical trial management system on Azure cloud technology to reduce risk and improve efficiencies in clinical development.

Curious about this latest version? Obtain Report Details @https://www.insightaceanalytic.com/report/global-clinical-trials-software-market-/1195

Market Segments

Global Clinical Trials Software Market, by Type of Deployment, 2022-2030 (Value US$ Mn)

  • On-cloud
  • On-premises

Global Clinical Trials Software Market, by Type of Delivery, 2022-2030 (Value US$ Mn)

  • Web-based
  • Remote Monitoring

Global Clinical Trials Software Market, by Features of software, 2022-2030 (Value US$ Mn)

  • EDC
  • eCOA/ePRO
  • eConsent

Global Clinical Trials Software Market, by End-Users, 2022-2030 (Value US$ Mn)

  • Pharmaceutical & Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Medical Device Manufacturers
  • Others

Global Clinical Trials Software Market, by Region, 2022-2030 (Value US$ Mn)

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

North America Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)

  • U.S.
  • Canada

Europe Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)

  • Germany
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe

Asia Pacific Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)

  • India
  • China
  • Japan
  • South Korea
  • Australia & New Zealand

Latin America Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)

  • Brazil
  • Mexico
  • Rest of Latin America

Middle East & Africa Clinical Trials Software Market, by Country, 2022-2030 (Value US$ Mn)

  • South Africa
  • GCC Countries
  • Rest of Middle East & Africa

Why should buy this market research report:

  • To receive a exaustive analysis of the prospects for the global clinical trials software market
  • To receive an industry overview and future industry trends of the clinical trials software market
  • To analyze the clinical trials software market drivers and challenges
  • To get information on the clinical trials software market size (Value US$ Mn) forecast to 2030
  • To receive information on sgnificant investments, mergers & acquisitions in the clinical trials softwareindustry

Other Related Reports Published by InsightAce Analytic:

Global Site Management Organizations (SMO) Market

Global Clinical Trial Imaging Services Market

Global AI-Based Clinical Trial Solution Providers Market

About Us:

InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain a competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets, and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.

Contact Us:

Priyanka Tilekar
InsightAce Analytic Pvt. Ltd.
Visit: www.insightaceanalytic.com
Tel: +1 551 226 6109
Asia: +91 79 72967118
Email: info@insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ

Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg

© 2022 PR Newswire
Treibt Nvidias KI-Boom den Uranpreis?
In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.